In Brief: Bio-Vascular
This article was originally published in The Gray Sheet
Executive Summary
Bio-Vascular: Expects accelerated European sales of its Peri-Strips Dry bovine pericardium-based staple line reinforcements in late 1997, when the company is scheduled to complete multi-center trials evaluating use of the products in lung volume reduction procedures performed on patients suffering from late-stage emphysema. The company commenced U.S. sales of the product, which replaces an earlier version of the Peri-Strips device, in mid-July following FDA clearance in early May...